1. Home
  2. FC vs CRBP Comparison

FC vs CRBP Comparison

Compare FC & CRBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FC
  • CRBP
  • Stock Information
  • Founded
  • FC 1983
  • CRBP 2009
  • Country
  • FC United States
  • CRBP United States
  • Employees
  • FC N/A
  • CRBP N/A
  • Industry
  • FC Other Consumer Services
  • CRBP Biotechnology: Pharmaceutical Preparations
  • Sector
  • FC Consumer Discretionary
  • CRBP Health Care
  • Exchange
  • FC Nasdaq
  • CRBP Nasdaq
  • Market Cap
  • FC 236.1M
  • CRBP 233.5M
  • IPO Year
  • FC 1992
  • CRBP N/A
  • Fundamental
  • Price
  • FC $16.98
  • CRBP $12.15
  • Analyst Decision
  • FC Strong Buy
  • CRBP Strong Buy
  • Analyst Count
  • FC 2
  • CRBP 9
  • Target Price
  • FC $27.00
  • CRBP $49.00
  • AVG Volume (30 Days)
  • FC 88.6K
  • CRBP 532.8K
  • Earning Date
  • FC 11-05-2025
  • CRBP 11-07-2025
  • Dividend Yield
  • FC N/A
  • CRBP N/A
  • EPS Growth
  • FC N/A
  • CRBP N/A
  • EPS
  • FC 0.81
  • CRBP N/A
  • Revenue
  • FC $279,943,000.00
  • CRBP N/A
  • Revenue This Year
  • FC N/A
  • CRBP N/A
  • Revenue Next Year
  • FC $1.23
  • CRBP $220.00
  • P/E Ratio
  • FC $20.89
  • CRBP N/A
  • Revenue Growth
  • FC N/A
  • CRBP N/A
  • 52 Week Low
  • FC $16.60
  • CRBP $4.64
  • 52 Week High
  • FC $44.16
  • CRBP $20.77
  • Technical
  • Relative Strength Index (RSI)
  • FC 38.33
  • CRBP 34.98
  • Support Level
  • FC $16.60
  • CRBP $16.20
  • Resistance Level
  • FC $19.52
  • CRBP $18.11
  • Average True Range (ATR)
  • FC 0.77
  • CRBP 1.70
  • MACD
  • FC -0.09
  • CRBP -0.64
  • Stochastic Oscillator
  • FC 11.87
  • CRBP 6.24

About FC Franklin Covey Company

Franklin Covey Co is a company focused on organizational performance improvement. It focuses on providing time management and effectiveness training for individuals and corporations via online training as well as in-person workshops and events. The company provides training and consulting services in the areas of leadership, execution, productivity, trust, sales performance, customer loyalty, and educational improvement. It operates in the business segments of Direct Offices, Education division, and International Licensees. The company derives revenue from providing training and consulting services, and through the selling of books, audio media, and other related products. It has a business presence in the Australia, New Zealand, China, Japan, United Kingdom, Ireland, and Other countries.

About CRBP Corbus Pharmaceuticals Holdings Inc.

Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.

Share on Social Networks: